Epigenomics AG (LON:0QXH)

London flag London · Delayed Price · Currency is GBP · Price in EUR
0.8820
-0.0080 (-0.90%)
At close: Nov 14, 2025
Market Cap672.26K -26.5%
Revenue (ttm)3.43K -97.1%
Net Income-2.37M
EPS-2.70
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume92
Average Volume2,720
Open0.8820
Previous Close0.8900
Day's Range0.8820 - 0.8820
52-Week Range0.8820 - 1.5000
Betan/a
RSI21.46
Earnings DateMar 25, 2026

About Epigenomics AG

Epigenomics AG does not have significant operations. Previously, the company was involved in liquid biopsy for the early detection of cancer. The company was founded in 1998 and is headquartered in Heidelberg, Germany. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1998
Employees 4
Stock Exchange London Stock Exchange
Ticker Symbol 0QXH
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements